Offen’s Lab of Translational Neuroscience
Felsenstein Medical Research Center
Dept. of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine
Sagol School of Neuroscience
Tel Aviv University
OUR PEOPLE
Principle Investigator
0523342737
Daniel Offen
Head, The Neuroscience Laboratory
Felsenstein Medical Research Center
Dept. of Human Molecular Genetics and Biochemistry,
Sackler Faculty of Medicine
Sagol school of Neuroscience
Tel Aviv University
Israel
Daniel Offen studied molecular biology, specializing in RNA processing, at the Weizmann Institute of Science, Israel. He furthered his education at the Albert Einstein College of Medicine, NY, USA, as a Post Doctoral Fellow where he developed transgenic models of autoimmunity. For many years, Offen has headed The Laboratory for Neurosciences at the Felsenstein Medical Research Center, Tel Aviv University. His work has concentrated on the processes of cell death in neurodegenerative diseases, specifically in Parkinson's and ALS. Recently, Professor Offen and his group have conducted pioneering work in the role of stem cells in health and disease. Offen's research has led to the publication of more than two hundred original articles, review papers and book chapters.
Prof. Offen is a co-founder of several biotechnology companies developing gene and cell therapies for neurological disorders. One of them, Brainstorm Cell Therapeutics, showed efficacy in ALS patients in a Phase III clinical trial.
Education
1980-1982 B.Sc. Faculty of Agriculture
The Hebrew University, Jerusalem
1985-1989 Ph.D. Feinberg Graduate School
The Weizmann Institute of Science, Rehovot
1989-1991 Postdoctoral Fellowship
Albert Einstein College of Medicine, New York, USA
Academic Position
Full Professor, Department of Human Genetics and Molecular Medicine, Sackler School of Medicine
Sagol School of Neuroscience
Tel Aviv University, Israel
Publications
http://www.ncbi.nlm.nih.gov/pubmed/?term=offen+d%2C
Patents
